BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holliday R. The extreme arrogance of anti-aging medicine. Biogerontology. 2009;10:223-228. [PMID: 18726707 DOI: 10.1007/s10522-008-9170-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 de Magalhães JP. The scientific quest for lasting youth: prospects for curing aging. Rejuvenation Res 2014;17:458-67. [PMID: 25132068 DOI: 10.1089/rej.2014.1580] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
2 Rattan SI, Singh R. Progress & prospects: gene therapy in aging. Gene Ther 2009;16:3-9. [PMID: 19005494 DOI: 10.1038/gt.2008.166] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
3 Rattan SIS. Naive extrapolations, overhyped claims and empty promises in ageing research and interventions need avoidance. Biogerontology 2020;21:415-21. [PMID: 31773357 DOI: 10.1007/s10522-019-09851-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rizvi SI, Jha R. Strategies for the discovery of anti-aging compounds. Expert Opin Drug Discov 2011;6:89-102. [PMID: 22646828 DOI: 10.1517/17460441.2011.533653] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Rattan SI. Healthy ageing, but what is health? Biogerontology 2013;14:673-7. [PMID: 23852043 DOI: 10.1007/s10522-013-9442-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
6 Whitehouse PJ. The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective. Biochem Pharmacol 2014;88:677-81. [PMID: 24304687 DOI: 10.1016/j.bcp.2013.11.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles. WJTM 2015;4:51. [DOI: 10.5528/wjtm.v4.i2.51] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Le Bourg E. Obsolete ideas and logical confusions can be obstacles for biogerontology research. Biogerontology 2013;14:221-7. [PMID: 23543307 DOI: 10.1007/s10522-013-9418-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
9 Jay Olshansky S, Biggs S, Andrew Achenbaum W, Davison GC, Fried L, Gutman G, Kalache A, Khaw K, Fernandez A, Rattan SIS, Guimarães RM, Milner C, Butler RN. The Global Agenda Council on the Ageing Society: Policy Principles: Global Population Ageing. Global Policy 2011;2:97-105. [DOI: 10.1111/j.1758-5899.2010.00053.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
10 Ly A, Shevelev A, Andres C, Pan XY, Trojan J. Mécanismes et pathologies du vieillissement. J Afr Cancer 2013;5:103-13. [DOI: 10.1007/s12558-013-0270-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Wilson DM, Cohen J, Birch S, Macleod R, Mohankumar D, Armstrong P, Froggatt K, Francke AL, Low G, Mccormack B, Hollis V, Williams A. “No One dies of Old Age”: Implications for Research, Practice, and Policy. J Palliat Care 2011;27:148-56. [DOI: 10.1177/082585971102700211] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]